Summary:
Click image to enlargeA clinical research study to look at the safety and effectiveness of different investigational drugs treating COVID-19 in participants that do not need hospitalization.
Qualified Participants Must:
• Be an adult 18+ years old
•
Sign informed consent
•
Test positive for COVID-19 up to 7 days prior to participation in the study
•
Be able to begin study treatment no later than days from self-reported onset of COVID-19 related symptoms
•
Have at least one sign/symptom of COVID-19 within 48 hours of participating in the study
Other study criteria apply. Contact a study coordinator to discuss your eligibility into this study.
Qualified Participants May Receive:
Participants will be given standard of care as well as study related drugs and treatment at no cost. Compensation may be available as well.